Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the PKD Foundation today announced a collaboration to investigate novel, orally-available small molecule kinase inhibitors of the…
Category: News
India fast becoming international destination for kidney transplants due to affordability & skill
India is a hub for affordable kidney transplants and has the best skills to carry out the procedures. The country is now recognized as a destination for kidney transplants by the international…
Turmeric may help rebuild brain cells
The molecular compound is made with curcumin, a natural yellow pigment that originates from a perennial herb called Curcuma longa and is popular in South Asian and Middle Eastern foods, particularly curries….
HHS lists GE PSO as part of AHRQ Patient Safety Organization program
The Secretary of Health and Human Services (HHS) has listed the GE-MERS National Patient Safety Organization (GE PSO) as part of the Agency for Healthcare Research and Quality’s (AHRQ) Patient Safety Organization…
Scientists discover new method for early diagnosis, treatment of plaque-related diseases
UC Santa Barbara scientists have made a discovery that has the potential for use in the early diagnosis and eventual treatment of plaque-related diseases such as Alzheimer’s disease and Type 2 diabetes….
Orthovita receives 510(k) clearance to market Vitoss BA Bimodal Bone Graft Substitute
Orthovita, Inc. (NASDAQ: VITA), an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Vitoss™ BA Bimodal Bone Graft Substitute…
New model of dementia care reduces emergency department visits, hospitalizations
An innovative model of dementia care developed by researchers at the Indiana University School of Medicine and the Regenstrief Institute significantly reduces emergency department visits and hospitalizations, and encourages use of medications…
Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS
Approved to dose last cohort of patients. Neuralstem, Inc. (NYSE Amex: CUR) updated the progress of its ongoing Phase I human clinical trial of the company’s spinal cord stem cells in the…
Dengue outbreak fears hit clean-up
NORTH Queensland residents have been warned to take precautions as an outbreak of dengue fever grips the Cassowary Coast in the wake of Cyclone Yasi. Ten cases of type-two dengue fever and…
Late to bed, rising early ups heart risk
Sleeping for less than six hours a night boosts the risk of dying from a heart attack or stroke. But beware—those who have too much sleep are also more likely to suffer…
Ovarian cancer `stimulus` probed
Australian researchers are probing the way hormonal changes in older women can provide a “stimulus” for ovarian cancer, in the hope of finding a new way to combat the tough-to-treat disease. Despite…
New findings of drug recently identified to prevent stroke in patients with AF published in NEJM
New findings from a McMaster University-led study of a drug recently identified to prevent stroke in patients with atrial fibrillation have been published in the high-impact New England Journal of Medicine (NEJM)…
Preladenant may offer new supplemental treatment for Parkinson’s disease
Study reports ‘off time’ reduced in those receiving standard dopamine therapy Tampa, FL (Feb. 10, 2011) — Preladenant, a non-dopaminergic medication, reduces off time in patients with Parkinson’s disease receiving standard dopamine…
Promedior initiates Phase 1b clinical study of PRM-151 in patients with IPF
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today that it has initiated a Phase 1b clinical study of PRM-151 to explore the…
Photodynamic Ablation Of Lymphatic Vessels And Intralymphatic Cancer Cells Prevents Metastasis
Tumor cells have several routes that enable them to move from the primary tumor to distant tissues, a process called metastasis. It is metastasis of the primary tumor that kills most cancer…